Antibiotic efficacy in vivo predicted by in vitro activity

被引：15
|
作者：
Mattie, H [1 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2000年 / 14卷 / 02期
关键词：
in vitro; in vivo; E-max;
D O I：
10.1016/S0924-8579(99)00145-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A brief overview of arguments found in the literature is presented to apply the E-max concept to experimental studies of antibiotics as well as to their clinical application. It may turn out to be more flexible than schedules based on arbitrary parameters that have the disadvantage that they have to be proven in each individual situation. (C) 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码：91 / 98
页数：8
相关论文
共 50 条
  • [1] Strong Antibiotic Activity of the Myxocoumarin Scaffold in vitro and in vivo
    Hertrampf, Gesa
    Kusserow, Kalina
    Vojnovic, Sandra
    Pavic, Aleksandar
    Mueller, Jonas, I
    Nikodinovic-Runic, Jasmina
    Gulder, Tobias A. M.
    CHEMISTRY-A EUROPEAN JOURNAL, 2022, 28 (32)
  • [2] Evaluation of the anticryptococcal activity of the antibiotic polymyxin B in vitro and in vivo
    Zhai, Bing
    Lin, Xiaorong
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (03) : 250 - 254
  • [3] In Silico Predicted Antifungal Peptides: In Vitro and In Vivo Anti-Candida Activity
    Ciociola, Tecla
    Magliani, Walter
    De Simone, Tiziano
    Pertinhez, Thelma A.
    Conti, Stefania
    Cozza, Giorgio
    Marin, Oriano
    Giovati, Laura
    JOURNAL OF FUNGI, 2021, 7 (06)
  • [4] Development of novel in vitro and in vivo models to evaluate antibiotic efficacy against shigellosis
    Arnold, Samuel
    McCloskey, Molly
    Shaheen, Shareef
    Hulverson, Matthew
    Choi, Ryan
    FASEB JOURNAL, 2018, 32 (01):
  • [5] Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri
    Molly C. McCloskey
    Shareef Shaheen
    Lesley Rabago
    Matthew A. Hulverson
    Ryan Choi
    Lynn K. Barrett
    Samuel L. M. Arnold
    Scientific Reports, 9
  • [6] Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri
    McCloskey, Molly C.
    Shaheen, Shareef
    Rabago, Lesley
    Hulverson, Matthew A.
    Choi, Ryan
    Barrett, Lynn K.
    Arnold, Samuel L. M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] ENDURACIDIN A NEW ANTIBIOTIC .3. IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY
    TSUCHIYA, K
    KONDO, M
    OISHI, T
    YAMAZAKI, T
    JOURNAL OF ANTIBIOTICS, 1968, 21 (02): : 147 - &
  • [8] Pharmacology, in vitro activity, and in vivo efficacy of new antifungal agents
    Wiederhold N.P.
    Current Fungal Infection Reports, 2009, 3 (2) : 77 - 85
  • [9] Pharmacology, In Vitro Activity, and In Vivo Efficacy of New Antifungal Agents
    Wiederhold, Nathan P.
    CURRENT FUNGAL INFECTION REPORTS, 2009, 3 (02) : 77 - 85
  • [10] In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia
    Nakamura, Rio
    Oota, Merime
    Matsumoto, Shuhei
    Sato, Takafumi
    Yamano, Yoshinori
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
12345